xemilofiban has been researched along with Bleeding in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anders, RJ; Burns, DM; Cove, CS; DeFranco, AC; Ellis, SG; Kottke-Marchant, K; Lowrie, M; Miller, DP; Moliterno, DJ; Raymond, RE; Simpfendorfer, C; Sutton, JM; Topol, EJ | 1 |
| Kereiakes, DJ | 1 |
| Alexander, J; Anders, R; Dreiling, R; Gong, J; Kleiman, J; Knudtson, M; O'Neill, WW; Roecker, EB; Serruys, P; Timmis, GC; van der Zwaan, C; van Es, GA | 1 |
| Jang, IK; Sabatine, MS | 1 |
| Bhatt, DL; Chew, DP; Sapp, S; Topol, EJ | 1 |
3 review(s) available for xemilofiban and Bleeding
| Article | Year |
|---|---|
Oral blockade of the platelet glycoprotein IIb/IIIa receptor: fact or fancy?
Topics: Abciximab; Administration, Oral; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Benzamidines; Clinical Trials as Topic; Drug Synergism; Epistaxis; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 1999 |
The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease.
Topics: Abciximab; Acetates; Acute Disease; Administration, Oral; Alanine; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Benzamidines; Coronary Disease; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Oximes; Peptides; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Randomized Controlled Trials as Topic; Stents; Syndrome; Thrombocytopenia; Thrombolytic Therapy; Tirofiban; Tyrosine | 2000 |
Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials.
Topics: Administration, Oral; Alanine; Aspirin; Benzamidines; Clinical Trials, Phase III as Topic; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemorrhage; Humans; Incidence; Multicenter Studies as Topic; Myocardial Infarction; Oximes; Piperidines; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Randomized Controlled Trials as Topic | 2001 |
2 trial(s) available for xemilofiban and Bleeding
| Article | Year |
|---|---|
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventions.
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Benzamidines; Coronary Artery Bypass; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex | 1997 |
Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events.
Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Benzamidines; Coronary Artery Bypass; Coronary Disease; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Stents; Thrombocytopenia | 2000 |